MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation

Background & Aims Ischemic-type biliary lesions (ITBL) are the second most common cause of graft loss after liver transplantation. Though the exact pathophysiology of ITBL is unknown, bile duct injury during graft preservation is considered to be a major cause. Here we investigated whether the r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepatology 2013-12, Vol.59 (6), p.1231-1238
Hauptverfasser: Verhoeven, Cornelia J, Farid, Waqar R.R, de Ruiter, Petra E, Hansen, Bettina E, Roest, Henk P, de Jonge, Jeroen, Kwekkeboom, Jaap, Metselaar, Herold J, Tilanus, Hugo W, Kazemier, Geert, van der Laan, Luc J.W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background & Aims Ischemic-type biliary lesions (ITBL) are the second most common cause of graft loss after liver transplantation. Though the exact pathophysiology of ITBL is unknown, bile duct injury during graft preservation is considered to be a major cause. Here we investigated whether the release of cholangiocyte-derived microRNAs (CDmiRs) during graft preservation is predictive of the development of ITBL after liver transplantation. Methods Graft preservation solutions (perfusates) and paired liver biopsies collected at the end of cold ischemia were analysed by RT-qPCR for CDmiR-30e, CDmiR-222, and CDmiR-296 and hepatocyte-derived miRNAs (HDmiRs) HDmiR-122 and HDmiR-148a. MicroRNAs in perfusates were evaluated on their stability by incubation and fractionation experiments. MicroRNA profiles in perfusates from grafts that developed ITBL (n = 20) and grafts without biliary strictures (n = 37) were compared. Results MicroRNAs in perfusates were proven to be stable and protected against degradation by interacting proteins. Ratios between HDmiRs/CDmiRs were significantly higher in perfusates obtained from grafts that developed ITBL ( p
ISSN:0168-8278
1600-0641
DOI:10.1016/j.jhep.2013.07.034